Practice Management News

Physicians generally use life insurance to achieve certain wealth planning goals — from protecting the family against the risk of a breadwinner’s early death to providing an estate for heirs and more.

“Ankylosing spondylitis”? “Sjögren’s syndrome”?

WASHINGTON — Addressing burnout in rheumatology will require attention to personal exhaustion and depersonalization, as well as systemic business-of-medicine issues, according to a speaker at ACR Convergence 2024.

BOSTON — To help patients with interstitial lung disease lower the chances of having a sick baby, physicians must have “honest and accurate conversations” with them before pregnancy, according to a presentation at the CHEST Annual Meeting.

WASHINGTON — Increased reimbursement and expanded educational opportunities are two key solutions to the workforce shortage in adult and pediatric rheumatology, according to two speakers at ACR Convergence 2024.

WASHINGTON — Among patients with systemic autoimmune rheumatic diseases, circulating interleukin-18 levels were lower in those with long COVID vs. those without, according to data presented at ACR Convergence 2024.

WASHINGTON — Biosimilar infliximab use is significantly more common among new users vs. those who started with the originator, and particularly less likely among Medicare beneficiaries, according to data presented at ACR Convergence 2024.

WASHINGTON — Patients with polymyalgia rheumatica were more likely to discontinue steroids after treatment with sarilumab than methotrexate, according to data presented at ACR Convergence 2024.

WASHINGTON — Practices that join the American College of Rheumatology’s RISE registry report “doubled to tripled” rates of improvement in rheumatoid arthritis function and disease activity assessment, according to data.

WASHINGTON — Inebilizumab is safe and effective in IgG4-related disease, significantly reducing the chance of flare through 52 weeks compared with placebo, according to data presented at ACR Convergence 2024.